【个人简介】

朱嵩，肿瘤学博士，广州医科大学附属清远医院（清远市人民医院）肿瘤中心主任助理、副研究员、主治医师；清远市第六类紧缺适用高层次人才，广东省医学会肿瘤学分会青年委员。

【研究方向】

恶性肿瘤发生发展的分子机制、肿瘤标志物筛查与预后影响；重点关注肿瘤复发转移

【科研项目】

1. 国家自然科学基金青年科学基金项目（2020年立项），主持；

2. 广州市教育局高校科研项目（2021–2022），主持；

3. 国家自然科学基金面上项目（2024年立项），主持。

【代表性论文及著作】

1. The role and mechanism of aerobic glycolysis in nasopharyngeal carcinoma. PeerJ. 2025 Apr 2. Review.

2. Macrophage marker gene-driven prognostic models for esophageal cancer: integrating multi-omics analysis and therapeutic strategies. 3 Biotech. 2025 Oct.

3. Clinical significance of serum lactate dehydrogenase combined with a multivariate model for predicting the near-term outcome of primary nasopharyngeal carcinoma. Life Sci. 2024 Aug 15.

4. Deciphering the code: the pivotal role of lncRNAs in advancing TNBC therapy. Front Oncol. 2024 Sep 2. Review.

5. K235 acetylation couples with PSPC1 to regulate the m6A demethylation activity of ALKBH5 and tumorigenesis. Nat Commun. 2023 Jun 27.

6. Advances in the study of aerobic glycolytic effects in resistance to radiotherapy in malignant tumors. PeerJ. 2023 Feb 16. Review.

7. An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis. Nat Commun. 2020 Apr 3.

8. Small Protein Hidden in lncRNA LOC90024 Promotes "Cancerous" RNA Splicing and Tumorigenesis. Adv Sci (Weinh). 2020 Mar 11.

9. TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer. Theranostics. 2019 Jan 24.

10. N6-Methyladenine DNA Modification in the Human Genome. Mol Cell. 2018 Jul 19.

11. A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. Mol Cell. 2017 Oct 5.

【所获荣誉和奖励】

清远市第六类紧缺适用高层次人才。